| Name | cimicifugoside |
|---|---|
| Synonyms | Prim-O-glucosylcimifygin |
| Description | Cimicifugoside, a triterpenoid isolated from Cimicifuga simplex, is a novel specific nucleoside transport inhibitor that displays synergistic potentiation of methotrexate cytotoxicity[1]. Cimicifugoside shows immunosuppressive activity, which is preferentially directed toward B-cell function with larger doses being required for suppression of T-cell function[2]. |
|---|---|
| Related Catalog | |
| Target |
Nucleoside transport[1] |
| References |
| Density | 1.38 g/cm3 |
|---|---|
| Molecular Formula | C37H54O11 |
| Molecular Weight | 674.81800 |
| Exact Mass | 674.36700 |
| PSA | 156.67000 |
| LogP | 2.94870 |
| Index of Refraction | 1.619 |